国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Staphylococcus carnosus Dihydrodipicolinate synthase (dapA) CSB-YP494801FLK
CSB-EP494801FLK
CSB-BP494801FLK
CSB-MP494801FLK
CSB-EP494801FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP494802FLK1
CSB-EP494802FLK1
CSB-BP494802FLK1
CSB-MP494802FLK1
CSB-EP494802FLK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus Ribosome-binding factor A (rbfA) CSB-YP494803FLK
CSB-EP494803FLK
CSB-BP494803FLK
CSB-MP494803FLK
CSB-EP494803FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus Tyrosine recombinase XerC (xerC) CSB-YP494804FLK
CSB-EP494804FLK
CSB-BP494804FLK
CSB-MP494804FLK
CSB-EP494804FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus UPF0122 protein Sca_0859 (Sca_0859) CSB-YP494805FLK
CSB-EP494805FLK
CSB-BP494805FLK
CSB-MP494805FLK
CSB-EP494805FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus Dihydroorotate dehydrogenase B (NAD (+)), catalytic subunit CSB-YP494806FLK
CSB-EP494806FLK
CSB-BP494806FLK
CSB-MP494806FLK
CSB-EP494806FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) CSB-YP494807FLK
CSB-EP494807FLK
CSB-BP494807FLK
CSB-MP494807FLK
CSB-EP494807FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus Serine--tRNA ligase (serS) CSB-YP494808FLK
CSB-EP494808FLK
CSB-BP494808FLK
CSB-MP494808FLK
CSB-EP494808FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP494809FLK
CSB-EP494809FLK
CSB-BP494809FLK
CSB-MP494809FLK
CSB-EP494809FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus carnosus Peptide chain release factor 3 (prfC), partial CSB-YP494810FLK
CSB-EP494810FLK
CSB-BP494810FLK
CSB-MP494810FLK
CSB-EP494810FLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis UPF0346 protein SUB0487 (SUB0487) CSB-YP494811FNR
CSB-EP494811FNR
CSB-BP494811FNR
CSB-MP494811FNR
CSB-EP494811FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis Glycogen synthase (glgA) CSB-YP494812FNR
CSB-EP494812FNR
CSB-BP494812FNR
CSB-MP494812FNR
CSB-EP494812FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis UPF0758 protein SUB0843 (SUB0843) CSB-YP494813FNR
CSB-EP494813FNR
CSB-BP494813FNR
CSB-MP494813FNR
CSB-EP494813FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis Uronate isomerase (uxaC) CSB-YP494814FNR
CSB-EP494814FNR
CSB-BP494814FNR
CSB-MP494814FNR
CSB-EP494814FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis Peptidyl-tRNA hydrolase (pth) CSB-YP494815FNR
CSB-EP494815FNR
CSB-BP494815FNR
CSB-MP494815FNR
CSB-EP494815FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis 30S ribosomal protein S19 (rpsS) CSB-YP494816FNR
CSB-EP494816FNR
CSB-BP494816FNR
CSB-MP494816FNR
CSB-EP494816FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis 50S ribosomal protein L29 (rpmC) CSB-YP494817FNR
CSB-EP494817FNR
CSB-BP494817FNR
CSB-MP494817FNR
CSB-EP494817FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis 30S ribosomal protein S8 (rpsH) CSB-YP494818FNR
CSB-EP494818FNR
CSB-BP494818FNR
CSB-MP494818FNR
CSB-EP494818FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis 30S ribosomal protein S11 (rpsK) CSB-YP494819FNR
CSB-EP494819FNR
CSB-BP494819FNR
CSB-MP494819FNR
CSB-EP494819FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus uberis D-tyrosyl-tRNA (Tyr) deacylase CSB-YP494820FNR
CSB-EP494820FNR
CSB-BP494820FNR
CSB-MP494820FNR
CSB-EP494820FNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>